2461524-68-3
C86H100N10O14
1497.8
Type 2 Diabetes; Weight loss
Tirzepatide
GLP-1, GIP
Availability: | |
---|---|
Product Description
Tirzepatide is a GIP receptor and GLP-1 receptor agonist. It is a 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding and prolongs the half-life. Tirzepatide selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1.
Tirzepatide enhances first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose dependent manner.
Tirzepatide Intermediate
This Tirzepatide intermediate, CAS No. 2461524-68-3, is a main chain of Tirzepatide.
Abbreviated as Fmoc-Phe-Val-Gin(Trt)-Trp(Boc)-Leu-lle-Ala-Gly-OH, it is an eight-peptide (P8), and the corresponding sequence on Tirzepatide is Peptide 22 to Peptide 29.